(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 14509.31 | 10965.73 | 32.32 | 14509.31 | 10965.73 | 32.32 | 52431.88 | 43819.24 | 19.65 |
| Other Income | 250.32 | 215.24 | 16.30 | 250.32 | 215.24 | 16.30 | 2095.16 | 1188.07 | 76.35 |
| PBIDT | 3646.15 | 2495.24 | 46.12 | 3646.15 | 2495.24 | 46.12 | 13342.66 | 7656.44 | 74.27 |
| Interest | 327.76 | 205.38 | 59.59 | 327.76 | 205.38 | 59.59 | 1182.71 | 1129.62 | 4.70 |
| PBDT | 3318.39 | 2254.86 | 47.17 | 3318.39 | 2254.86 | 47.17 | 11909.24 | 6526.82 | 82.47 |
| Depreciation | 631.66 | 598.17 | 5.60 | 631.66 | 598.17 | 5.60 | 2467.33 | 2249.72 | 9.67 |
| PBT | 2686.73 | 1656.69 | 62.17 | 2686.73 | 1656.69 | 62.17 | 9441.91 | 4277.10 | 120.75 |
| TAX | 685.65 | 428.80 | 59.90 | 685.65 | 428.80 | 59.90 | 2112.32 | 1105.82 | 91.02 |
| Deferred Tax | -17.82 | -11.23 | 58.68 | -17.82 | -11.23 | 58.68 | -225.09 | -21.25 | 959.25 |
| PAT | 2001.08 | 1227.89 | 62.97 | 2001.08 | 1227.89 | 62.97 | 7329.59 | 3171.28 | 131.12 |
| Equity | 1896.80 | 1895.08 | 0.09 | 1896.80 | 1895.08 | 0.09 | 1895.90 | 1894.83 | 0.06 |
| PBIDTM(%) | 25.13 | 22.75 | 10.44 | 25.13 | 22.75 | 10.44 | 25.45 | 17.47 | 45.64 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1944.85 |
| Dr. Reddys Labs. | 1163.40 |
| Cipla | 1465.60 |
| Lupin | 2400.90 |
| Zydus Lifesciences | 1102.35 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: